Published in Am J Gastroenterol on December 12, 2007
Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol (2012) 2.68
Diagnosis and Management of Functional Heartburn. Am J Gastroenterol (2016) 1.45
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol (2012) 1.28
NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol (2013) 1.20
Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19
Esophageal sensation and esophageal hypersensitivity - overview from bench to bedside. J Neurogastroenterol Motil (2010) 1.15
Raised intensity phonation compromises vocal fold epithelial barrier integrity. Laryngoscope (2011) 1.06
Luminal chemosensing and upper gastrointestinal mucosal defenses. Am J Clin Nutr (2009) 1.02
Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med (2016) 0.92
Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis. World J Gastroenterol (2009) 0.90
Gastrointestinal mucosal barrier function and diseases. J Gastroenterol (2016) 0.85
Role of corticotrophin-releasing factor in the stress-induced dilation of esophageal intercellular spaces. J Korean Med Sci (2011) 0.84
Is intercellular space different among layers in normal esophageal mucosa? An electron microscopic study. Dig Dis Sci (2011) 0.83
Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract (2013) 0.83
Distinction between patients with non-erosive reflux disease and functional heartburn. Ann Gastroenterol (2013) 0.79
Acid burn or cytokine sizzle in the pathogenesis of heartburn? J Gastroenterol Hepatol (2013) 0.77
Managing gastroesophageal reflux disease in children: The role of endoscopy. World J Gastrointest Endosc (2012) 0.76
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol (2017) 0.76
Patients with refractory gastroesophageal reflux disease: diagnostic tools. Ann Gastroenterol (2013) 0.75
Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone? World J Gastroenterol (2015) 0.75
The Relationship of the Post-reflux Swallow-induced Peristaltic Wave Index and Esophageal Baseline Impedance with Gastroesophageal Reflux Disease Symptoms. J Neurogastroenterol Motil (2017) 0.75
Role of Ultrastructural Alterations of Intercellular Junction and Tight-junction Proteins in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil (2013) 0.75
Esophageal Intraepithelial Neutrophil Infiltration is Common in Nigerian Patients With Non-Erosive Reflux Disease. Gastroenterology Res (2011) 0.75
Relationship Between Salivary Pepsin Concentration and Esophageal Mucosal Integrity in Patients With Gastroesophageal Reflux Disease. J Neurogastroenterol Motil (2017) 0.75
Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol (2004) 3.04
Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol (2013) 2.98
The acid pocket: a target for treatment in reflux disease? Am J Gastroenterol (2013) 2.41
Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut (2013) 2.26
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis. Am J Gastroenterol (2013) 2.21
Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol (2009) 2.10
Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol (2006) 2.00
Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology (2010) 1.89
Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics (2006) 1.82
In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease. Gut (2012) 1.64
Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux. Am J Gastroenterol (2005) 1.56
High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology (2008) 1.51
Botulinum toxin reduces Dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol (2013) 1.50
[Comparative prospective study of two positioning modes of 24-hour esophageal pH monitoring: by esophageal manometry and by the pH step-up technique]. Arq Gastroenterol (2009) 1.39
Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut (2011) 1.32
Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut (2009) 1.31
High-resolution Manometry: Esophageal Disorders Not Addressed by the "Chicago Classification". J Neurogastroenterol Motil (2012) 1.26
Gastroesophageal reflux and gastric emptying, revisited. Curr Gastroenterol Rep (2005) 1.13
Gastric and lower esophageal sphincter pressures during nausea: a study using visual motion-induced nausea and high-resolution manometry. Am J Physiol Gastrointest Liver Physiol (2014) 1.11
Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J Heart Lung Transplant (2009) 1.11
Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut (2007) 1.11
Case report: achalasia-like dysmotility secondary to oesophageal involvement of sarcoidosis. Gut (2010) 1.07
Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol (2012) 1.07
Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci (2008) 1.04
Airway colonization and gastric aspiration after lung transplantation: do birds of a feather flock together? J Heart Lung Transplant (2008) 0.97
Objective detection of esophagopharyngeal reflux in patients with hoarseness and endoscopic signs of laryngeal inflammation. J Clin Gastroenterol (2014) 0.96
Mechanisms of gastroesophageal reflux in critically ill mechanically ventilated patients. Gastroenterology (2005) 0.94
Different responsiveness of excitatory and inhibitory enteric motor neurons in the human esophagus to electrical field stimulation and to nicotine. Am J Physiol Gastrointest Liver Physiol (2004) 0.93
Gastric juice from patients "on" acid suppressive therapy can still provoke a significant inflammatory reaction by human bronchial epithelial cells. J Clin Gastroenterol (2010) 0.93
The role of weakly acidic reflux in proton pump inhibitor failure, has dust settled? J Neurogastroenterol Motil (2010) 0.92
Mechanisms of heartburn. Nat Clin Pract Gastroenterol Hepatol (2008) 0.92
Changes in gastrointestinal tract function and structure in functional dyspepsia. Nat Rev Gastroenterol Hepatol (2013) 0.91
Gastrointestinal motility changes and myenteric plexus alterations in spontaneously diabetic biobreeding rats. J Neurogastroenterol Motil (2013) 0.91
Dietary restrictions during ambulatory monitoring of duodenogastroesophageal reflux. Dig Dis Sci (2003) 0.90
GERD-related chronic cough: how to identify patients who will respond to antireflux therapy? J Clin Gastroenterol (2010) 0.90
Acid and non-acid reflux patterns in patients with erosive esophagitis and non-erosive reflux disease (NERD): a study using intraluminal impedance monitoring. Dig Dis Sci (2008) 0.90
Oesophageal shortening: in vivo validation of high-frequency ultrasound measurements of oesophageal muscle wall thickness. Gut (2010) 0.90
A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol (2004) 0.90
Assessment and protection of esophageal mucosal integrity in patients with heartburn without esophagitis. Am J Gastroenterol (2013) 0.87
Influence of sildenafil on gastric sensorimotor function in humans. Am J Physiol Gastrointest Liver Physiol (2004) 0.87
The role of gastro-oesophageal pressure gradient and sliding hiatal hernia on pathological gastro-oesophageal reflux in severely obese patients. Eur J Gastroenterol Hepatol (2010) 0.87
Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am J Gastroenterol (2012) 0.86
Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol (2012) 0.86
Esophageal mucosal integrity in nonerosive reflux disease. J Clin Gastroenterol (2014) 0.85
New pharmacologic approaches in gastroesophageal reflux disease. Gastroenterol Clin North Am (2010) 0.85
Oesophageal mucosal barrier: a key factor in the pathophysiology of non-erosive reflux disease (NERD) and a potential target for treatment. Gut (2013) 0.84
Cough and gastroesophageal reflux: from the gastroenterologist end. Pulm Pharmacol Ther (2008) 0.84
New developments in detection of gastroesophageal reflux. Curr Opin Gastroenterol (2005) 0.81
The refluxate: The impact of its magnitude, composition and distribution. Best Pract Res Clin Gastroenterol (2010) 0.81
Gastroesophageal reflux and atypical symptoms: the role of impedance-pH monitoring. Digestion (2007) 0.80
The effect of gastric juice on interleukin-8 production by cystic fibrosis primary bronchial epithelial cells. J Cyst Fibros (2013) 0.79
Developments in pathogenesis and diagnosis of gastroesophageal reflux disease. Curr Opin Gastroenterol (2007) 0.79
Increased prandial air swallowing and postprandial gas-liquid reflux among patients refractory to proton pump inhibitor therapy. Clin Gastroenterol Hepatol (2013) 0.79
Evolving pharmacological approaches in gastroesophageal reflux disease. Expert Opin Emerg Drugs (2012) 0.79
Pathophysiology of GERD in China: the same factors at a lower scale. Am J Gastroenterol (2004) 0.78
Nocturnal gastroesophageal reflux revisited by impedance-pH monitoring. J Neurogastroenterol Motil (2011) 0.78
Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping. Clin Gastroenterol Hepatol (2008) 0.77
Influence of 5-HT1 receptor agonists on feline stomach relaxation. Eur J Pharmacol (2004) 0.77
Reflux cough. Curr Gastroenterol Rep (2008) 0.77
The neurophysiology of the esophagus. Ann N Y Acad Sci (2013) 0.77
Management of gastro-oesophageal reflux disease symptoms that do not respond to proton pump inhibitors. Curr Opin Gastroenterol (2013) 0.77
World gastroenterology organisation global guidelines: dysphagia--global guidelines and cascades update September 2014. J Clin Gastroenterol (2015) 0.76
Relevance of GERD in lung transplant patients. Curr Gastroenterol Rep (2010) 0.76
Physiology of the upper segment, body, and lower segment of the esophagus. Ann N Y Acad Sci (2013) 0.75
Use of Solid Boluses in High-resolution Manometry. J Neurogastroenterol Motil (2013) 0.75
Impact of bolus volume on small intestinal intra-luminal impedance in healthy subjects. World J Gastroenterol (2010) 0.75
Validation of octanoate breath test for measuring gastric emptying in rats. J Neurogastroenterol Motil (2013) 0.75
Barrett's esophagus: proton pump inhibitors and chemoprevention I. Ann N Y Acad Sci (2011) 0.75
Emerging therapeutic options in GERD. Best Pract Res Clin Gastroenterol (2013) 0.75
New pharmacologic approaches in gastroesophageal reflux disease. Thorac Surg Clin (2011) 0.75
[Measurement of esophageal impedance in gastro-esophageal reflux disease: results and perspectives]. Gastroenterol Clin Biol (2003) 0.75
Tissue resistance in the normal and diseased esophagus. Ann N Y Acad Sci (2013) 0.75
Diagnostic options for patients with refractory GERD. Curr Gastroenterol Rep (2008) 0.75
Functional esophageal disorders: pharmacological options. Drugs (2014) 0.75
Supragastric belching. Curr Opin Gastroenterol (2016) 0.75
Testing for gastroesophageal reflux in the 21st century. Ann N Y Acad Sci (2011) 0.75
Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75